Prognostic associations of tumor-infiltrating lymphocytes (TIL) in metastatic HER2-positive breast cancer (BC) treated with trastuzumab and pertuzumab: a secondary analysis of the CLEOPATRA study
Institution: Washington Cancer InstituteForm of publication: ConferenceYear: 2016Conference information: Conference presentation at: 2016 San Antonio Breast Cancer Symposium (SABCS), San Antonio, TX , 2016/12/05Fiscal year: FY2017Local accession number: 2016_346Date added to catalog: 2017-05-06| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Conference | MedStar Authors Catalog | Conference | Available |